The Ascension Life Fund has adopted an investment approach that focuses on four key elements of any potential business: the quality of the team, the strength of the intellectual property, the robustness of the technology vs. competition, and market size/potential of the product.
The focus is on UK HealthTech and Life Sciences companies raising Seed+ funding rounds that bridge the equity gap between Seed and Series A rounds.
EIS investing can offer favourable tax reliefs
April 4th 2022
The Ascension Life Fund’s industry and investment experience has led it to focus on six areas where it feels above average returns are achievable:
The Fund’s competitive advantage is driven by an exceptional team of operators and network of advisors (20+), with extensive experience and expertise within the specific investment themes. The extended network has benefits throughout the investment life cycle from qualified deal origination and technical due diligence to post-investment support and follow-on funding.
Özgür Tuncer - Investment Partner
David Buller - Investment Partner
Chris Wheatcroft - Investment Director
Dr. Ala Alenazi - Investment Associate